Drug Metabolism and Transport
Showing 1 - 25 of >10,000
Drug Metabolism and Transport
Active, not recruiting
- Transgender Persons
- Midazolam oral solution
- +2 more
-
Seattle, WashingtonUniversity of Washington
Dec 21, 2022
Effect of Estrogen Treatment on Drug Metabolism and Transport
Not yet recruiting
- Transgender Persons
- Midazolam oral solution
- +2 more
- (no location specified)
Jul 19, 2022
Drug Interaction Trial in San Antonio (Ecopipam, Cohort 1 Probe Substrate Cocktail, Cohort 2 Probe Substrate)
Completed
- Drug Interaction
- Ecopipam
- +3 more
-
San Antonio, TexasICON Early Phase Services
Dec 9, 2022
Cholesterol, HDL, Lipid Metabolism, Inborn Errors, Tangier Disease Trial in Philadelphia (3H-cholesterol bound to albumin)
Suspended
- Cholesterol, HDL
- +4 more
- 3H-cholesterol bound to albumin
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 14, 2022
Drug-Interactions Trial in Miami (ecopipam HCl ~2mg/kg/day, Cohort 1 Probe Cocktail, Cohort 2 Probe Cocktail)
Terminated
- Drug-Interactions
- ecopipam HCl ~2mg/kg/day
- +3 more
-
Miami, FloridaSyneos Health Clinical Research Services, LLC.
May 20, 2021
Diabete Type 2 Trial in New Haven (Intensification of insulin regimen/Nutrition)
Suspended
- Diabete Type 2
- Intensification of insulin regimen/Nutrition
-
New Haven, ConnecticutYale New Haven Hospital
Jan 13, 2023
Obesity Trial in New Haven (Intralipid, 20% Intravenous Emulsion, Placebos)
Recruiting
- Obesity
- Intralipid, 20% Intravenous Emulsion
- Placebos
-
New Haven, ConnecticutYale School of Medicine
May 12, 2022
Diabetes, Type 2 Trial (Magnetic Resonance Spectroscopy Imaging (MRSI))
Not yet recruiting
- Diabetes Mellitus, Type 2
- Magnetic Resonance Spectroscopy Imaging (MRSI)
- (no location specified)
Mar 8, 2023
BHB Transport, Alcohol Use Disorder Trial (Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans)
Not yet recruiting
- BHB Transport
- Alcohol Use Disorder
- Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans
- (no location specified)
Jun 30, 2023
Metabolism, Infection, and Immunity in Inborn Errors of
Recruiting
- Oxidative Phosphorylation Deficiencies
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Energy Metabolism Trial in Santander, Madrid (Intervallic submaximal exercise test)
Recruiting
- Energy Metabolism
- Intervallic submaximal exercise test
-
Santander, Cantabria, Spain
- +1 more
Oct 24, 2023
Brain Metabolism Observed at 7 Tesla
Recruiting
- Glut1 Deficiency Syndrome 1
- +6 more
- Magnetic resonance imaging
-
Dallas, TexasUT Southwestern Medical Center
Aug 24, 2022
Molecular Basis of Altered Drug Metabolism During Pregnancy
Withdrawn
- Pregnancy
-
Chicago, IllinoisNorthwestern University Asher Center for the Study and Treatment
Sep 26, 2022
Healthy Volunteers, Overweight Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Sucralose, Placebo)
Suspended
- Healthy Volunteers
- Overweight
- Sucralose
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Diabetes, Type 2 Trial in Odense (Metformin, Caffeine, Efavirenz)
Terminated
- Diabetes Mellitus, Type 2
- Metformin
- +6 more
-
Odense, Region Of Southern Denmark, DenmarkUniversity of Southern Denmark
Jun 14, 2022
Healthy Volunteers Trial in Tempe (TAK-279, Erythromycin, Phenytoin)
Not yet recruiting
- Healthy Volunteers
- TAK-279
- +3 more
-
Tempe, ArizonaCelerion - Tempe, AZ Site
Aug 9, 2023
Microbial Colonization Trial in Somerville (Tolcapone 100 MG, Duloxetine 20 MG)
Recruiting
- Microbial Colonization
- Tolcapone 100 MG
- Duloxetine 20 MG
-
Somerville, New JerseyRobert Wood Johnson University Hospital Somerset
Apr 29, 2022
COPD Trial in Antwerp (CHF 5993 pMDI, Cimetidine plus CHF5993 pMDI)
Completed
- COPD
- CHF 5993 pMDI
- Cimetidine plus CHF5993 pMDI
-
Antwerp, BelgiumLife Science Services SGS Belgium NV
Oct 28, 2021
Epilepsy, GLUT1DS1, Glut1 Deficiency Syndrome 1, Autosomal Recessive Trial in Dallas (Triheptanoin)
Active, not recruiting
- Epilepsy
- +6 more
-
Dallas, TexasUT Southwestern Medical Center
Feb 1, 2022
Healthy Volunteers Trial in Madison ([14C]-Fosgonimeton)
Active, not recruiting
- Healthy Volunteers
-
Madison, WisconsinLabcorp Clinical Research Unit
Aug 19, 2022
Diabetes, Insulin Resistance, Glucose Metabolism Disorders Trial in Grenoble (6-DIG, clamp)
Completed
- Diabetes Mellitus
- +4 more
- 6-DIG
- clamp
-
Grenoble, FranceHôpital Michallon . CHU Grenoble
Aug 25, 2021
Bile Acids in Acute Insulin Resistance
Recruiting
- PI3K Gene Mutation
- +4 more
- Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
-
New York, New YorkColumbia University Medical Center
Oct 6, 2022